(no text — see the shared post below)
Circulating oxidized LDL is a poor test; measure ApoB instead, says Dayspring
Tom Dayspring argues that oxidized LDL measured in the bloodstream is a 'useless' biomarker and that ApoB should be measured instead. Louis adds that this refers to circulating oxidized LDL, not oxidized LDL inside plaques, which still matters but cannot be measured by blood test. Newer studies that adjust for ApoB reportedly show circulating oxidized LDL is not related to CVD risk.


